action of glp-1 agonist Mechanism of agonists GLP1-GIP receptor co-agonists: a promising

Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

You may be consuming too much fiber

Nat Rev Endocrinol (2019) 15:28898

GLP-1-induced weight loss directly translates to reduced joint stress, slowing cartilage degradation and improving mobility

At Nice, clinicians treat weight challenges and obesity like any other chronic conditionwith a sustainable, long-term plan that combines medication, nutrition, and movement

The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74